Get the latest news alerts: at Twitter.

Local Tech Wire

RESEARCH TRIANGLE PARK, N.C. – Eric Linsley, a veteran executive at , is being promoted to managing partner at the venture capital firm.

"Eric is a savvy investor, an experienced operating executive and a strategist who exemplifies the vision of Pappas Ventures,” said Art Pappas, the founder and managing partner of the firm. "By making this move today, we are recognizing the key role that Eric has played for some time – and will play going forward. As we share senior management responsibilities, we will continue to create value for our investors, further building upon our successful, 15-year track record in identifying growth opportunities and leading life science venture investments that change the way medicine is practiced.”

Linsley joined Pappas Ventures in 2000.

Pappas focuses on life science investments with more than 25 companies in its portfolio and more than $350 million under management.

At Pappas, Linsley has been involved in three startups that were later acquired:

• Peninsula Pharmaceuticals, by Johnson & Johnson
• Cerexa, by Forest Laboratories
• Panacos Pharmaceuticals, which joined with VI Technologies through a reverse merger

Linsley has also been involved in the raising of three new funds for Pappas, including the most recent which closed on $102 million. He has been involved in the venture industry for 18 years and was chief financial officer at TriPath Imaging (now part of Becton Dickinson) before joining Pappas.

A graduate of Trinity College with a degree in economics, Linsley earned a Master’s in accounting at New York University and a Master’s in business at the University of Pennsylvania’s Wharton School.